Almasood Abdullah A
General Practice, ABC Medical Center, Riyadh, SAU.
Cureus. 2024 Sep 3;16(9):e68556. doi: 10.7759/cureus.68556. eCollection 2024 Sep.
Psoriasis is a chronic inflammatory skin condition characterized by well-demarcated, erythematous plaques. Certain medications, including Angiotensin-Converting Enzyme (ACE) inhibitors, have been implicated as potential triggers for psoriasis flare-ups. We report the case of a 48-year-old Indian male with a history of well-controlled plaque psoriasis who experienced severe flare-ups after initiating ACE inhibitor therapy for hypertension. Within two weeks, the patient developed widespread psoriatic plaques accompanied by intense pruritus and discomfort, strongly suggesting a drug-induced reaction. Discontinuation of the ACE inhibitor led to a gradual improvement in symptoms, managed with topical corticosteroids and emollients, and switching to an alternative antihypertensive medication resulted in no further exacerbation of psoriasis. This case underscores the potential for ACE inhibitors to trigger psoriasis flare-ups in susceptible individuals, highlighting the need for clinicians to be vigilant when prescribing these medications to patients with a history of psoriasis. Further studies are needed to elucidate the underlying mechanisms and identify patients at risk.
银屑病是一种慢性炎症性皮肤病,其特征为边界清晰的红斑斑块。某些药物,包括血管紧张素转换酶(ACE)抑制剂,被认为是银屑病发作的潜在诱因。我们报告了一例48岁的印度男性病例,该患者有斑块状银屑病病史且病情控制良好,但在开始使用ACE抑制剂治疗高血压后出现了严重的病情发作。在两周内,患者出现了广泛的银屑病斑块,并伴有强烈的瘙痒和不适,强烈提示为药物性反应。停用ACE抑制剂后症状逐渐改善,采用外用皮质类固醇和润肤剂进行治疗,改用另一种抗高血压药物后银屑病未再加重。该病例强调了ACE抑制剂在易感个体中引发银屑病发作的可能性,突出了临床医生在给有银屑病病史的患者开这些药物时需要保持警惕。需要进一步研究以阐明潜在机制并识别有风险的患者。